CDSCO

‘B.1.617.2 May Be 50% More Contagious Than Variant First Seen in UK’

COVID in India: 35 Questions for K. VijayRaghavan, V.K. Paul and Balram Bhargava

Bharat Biotech To See if Third Covaxin Dose Can Provide Protection for Longer

Brazil’s Health Regulator Anvisa Says Covaxin Doesn’t Meet Manufacturing Standards

Home Secy Ajay Bhalla Asks States To Prosecute People for Vaccine Safety ‘Rumours’

Watch | ‘Why Authorise a Vaccine Without Phase 3 Efficacy?’: Gagandeep Kang

Bharat Biotech, Serum Institute End Spat, Pledge ‘Smooth Rollout’ of Vaccines